Innate Pharma

Innate Pharma reports operating revenue of 7.7 million euros for 2009

February 5, 2010

(IFRS unaudited provisional data)
Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) announces an operating revenue of 7.7 million euros for the year 2009. Turnover for the year amounted 3.3 million euros, including 0.5 million euros in the fourth quarter ended December 31, 2009.

Number of shares and voting rights and cash situation of INNATE PHARMA as at December 31, 2009

January 8, 2010

Following the capital increase reserved to categories of investors executed in December 2009 and pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (“AMF”) charter, Innate Pharma SA updates its total number of shares outstanding as well as its voting rights as at December 31, 2009: